Abstract
Case report
We present the case of a 25-year-old woman with treatment resistant hyperemesis gravidarum in the 15th week with a 13 kg loss of body weight. When the patient asked for termination of the pregnancy because of the unbearable symptoms, treatment with intravenous mirtazapine (Remergil) was started.
Results
Nausea and vomiting disappeared within hours, pregnancy termination was no longer desired. The patient was discharged two weeks later in good health and at 36 weeks gestation a cesarean section was performed. Post partum evaluation as well as 6-month post-partum revealed no dysmorphology or laboratory abnormalities in the children.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aikins Murphy P (1998) Alternative therapies for nausea and vomiting of pregnancy. Obstet Gynecol 91:149–155
Buckwalter JG, Simpson SW (2002) Psychological factors in the etiology and treatment of severe nausea and vomiting in pregnancy. Am J Obstet Gynecol 186 [Suppl]:210–214
Dorn C, Pantlen A, Rohde A (2002) Mirtazapine (Remergil®): Behandlungsoption bei therapieresistenter Hyperemesis gravidarum? Ein Fallbericht. Geburtsh Frauenheilk 62:1–4
Eliakim R, Abulafia O, Sherer DM (2000) Hyperemesis gravidarum: a current review. Am J Perinatol 17:207–218
Goodwin TM (2002) Nausea and vomiting of pregnancy: an obstetrics syndrome. Am J Obstet Gynecol 186 [Suppl]:184–189
Koren G, Levichek Z (2002) The teratogenicity of drugs for nausea and vomiting of pregnancy: perceived versus true risk. Am J Obstet Gynecol 186 [Suppl]:248–252
Magee LA, Mazotta P, Koren G (2002) Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol 186 [Suppl]:256–261
Mazzotta P, Stewart DE, Koren G, Magee L (1997) Therapeutic abortion due to severe NVP: unacceptable combination. Can Fam Phys 43:1055–1057
Mazzotta P, Stewart DE, Koren G, Magee L (2001) Factors associated with elective termination of pregnancy among Canadian and American women with NVP. J Psychosom Obstet Gynecol 22:1–2
Miller F (2002) Nausea and vomiting in pregnancy: the problem of perception—is it really a disease? Am J Obstet Gynecol 186 [Suppl]:182–183
Montgomery SA (1995) Safety of mirtazapine: a review. Int Clin Psychopharmacol 10 [Suppl]:37–45
Niebyl JR, Goodwin TM (2002) Overview of nausea and vomiting of pregnancy with an emphasis on vitamins and ginger. Am J Obstet Gynecol 186 [Suppl]:253–255
Saks B (2001) Mirtazapine: treatment of depression, anxiety, and gravidarum in the pregnant patient. A report of 7 cases. Arch Womens Ment Health 3:165–170
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rohde, A., Dembinski, J. & Dorn, C. Mirtazapine (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy. Arch Gynecol Obstet 268, 219–221 (2003). https://doi.org/10.1007/s00404-003-0502-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-003-0502-0